The Next Era of Anticoagulation: Assessing the Safety Profile and Indication Expansion Driving the Apixaban Market Trajectory
The Apixaban Market has fundamentally redefined the landscape of oral anticoagulation therapy, emerging as a preferred choice for physicians managing conditions like non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE). Its rapid rise is largely attributable to its well-documented and favorable safety profile, particularly concerning the risk of major bleeding events...
0 Commenti 0 condivisioni 913 Views 0 Anteprima